Physician profile
Hong Ren
NPI 1750716866
$2,711.45
in general payments reported to CMS, 2019-2025
9 companies · $754 in 2025
The $754 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2022: $442 · 2023: $942 · 2024: $471 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,166.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $815.88 | 2022-2025 | Datroway, Enhertu, Lynparza |
| Stemline Therapeutics INC. | $605.02 | 2023-2025 | Orserdu |
| Lilly USA, LLC | $537.46 | 2022-2025 | Verzenio |
| Seagen INC. | $237.21 | 2022-2023 | Tukysa |
| Abbvie INC. | $125.00 | 2025 | |
| Pfizer INC. | $125.00 | 2024 | |
| Daiichi Sankyo INC. | $120.11 | 2023 | Enhertu |
| Nevro Corp. | $102.96 | 2019 | |
| Telix Pharmaceuticals | $42.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hong Ren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.